Table 1.
Phase | Biological Activity | Biomarkers | Reference |
---|---|---|---|
Prior to ART initiation |
Granulocyte activation, systemic oxidative stress | ↑ oxidases, arginases, integrins, matrix metalloproteinases (MMP), etc. | Musubire et al., 2018 [78] Vlasova-St. Louis et al., 2018 [31] |
Prior to ART initiation |
Transcriptomic profiles of peripheral mononuclear cells | ↓ type I interferons (IFN I), antiviral defense gene expression | Vlasova-St. Louis et al., 2018 [31] |
In vitro stimulated mononuclear cells | ↓ interferon-gamma (IFN-γ) | Chang et al., 2013 [77] | |
Activated monocyte status Activated CD14+CD16++ monocyte |
↑ IL-6, C-reactive protein, serum amyloid A and D-dimer, sCD14, ↑ TNF-α and IL-6 |
Sandler et al., 2011 [79] Meya et al., 2017 [80] |
|
Increased levels of blood cytokines and chemokines | IL-6, IL-18, TNF-α, IL-5, IL-7, IL-17, GM-CSF, CCL11, and CXCL10 | Meya et al., 2019 [84] Rateni et al., 2018 [85] Akilimali et al., 2017 [86] |
|
Poor B cell function upon stimulation with | ↓ IgM antibodies secretion in response to Cryptococcal antigens | Yoon et al., 2019 [28] | |
At the time of CM-IRIS events | Transcriptomic profiles of peripheral mononuclear cells | Early CM-IRIS: ↑ inflammasome components: IL1B, Casp1, AIM2 NAIP, NLRP3, etc. Late CM-IRIS: ↑ IFNG, IL27, KLRB1, CD3, CD247, CD8, IL2RB |
Vlasova-St. Louis et al., 2018 [31] |
Abbreviations: ↑ increase; ↓ decrease; CM-IRIS—cryptococcal meningitis IRIS; ART—antiretroviral therapy; IFN—interferon; IL—interleukin; TNF—tumor necrosis factor; GM-CSF—granulocyte-macrophage colony-stimulating factor; CNS—central nervous system; sCD14—soluble CD14.